SEC Form 4 · accession 0001179110-17-013788
Teladoc Health, Inc. · TDOC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Peter A McClennen
Officer — President
Period of report
Nov 3, 2017
Accepted (ET)
Nov 6, 2017 · 6:15 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001477449
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Employee Stock Option (right to buy)F1 | $32.50 | Nov 3, 2017 | A | 226,128 | A | — | Nov 3, 2027 | Common Stock | 226,128 | 226,128 | D |
| Restricted Stock UnitsF2,F3 | — | Nov 3, 2017 | A | 50,769 | A | — | Nov 3, 2027 | Common Stock | 50,769 | 50,769 | D |
Explanation of responses
- F1The option will vest as to 25% of the shares on November 3, 2018. The remainder of the shares will vest in 36 equal monthly installments thereafter.
- F2Each restricted stock unit represents a contingent right to receive one share of TDOC common stock.
- F3The restricted stock unit vests in four equal annual installments beginning on November 3, 2018.